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ABSTRACT  We  performed  immunohistochemical  studies of chicken  oviduct after different 
fixation  procedures, by using antibodies against the progesterone receptor:  polyclonal  anti- 
bodies  IgG-G3 against the  "8S" form  (an  oligomere  containing  progesterone-binding  and 
nonprogesterone-binding  units), polyclonal antibodies IgG-RB against the progesterone-bind- 
ing  B subunit,  and  monoclonal  BF4  against the  non-progesterone-binding  90,000-mol-wt 
protein component.  Chickens were immature animals with or without estrogen priming, and 
with  or  without  progesterone  treatment.  The  antibodies  were  revealed by  means of  an 
immunoperoxidase technique that used the avidin-biotin-peroxidase complex, and controls 
were  performed  by presaturation of antibodies with the  purified  8S-progesterone receptor, 
the B subunit, and 90,000-mol-wt  protein. 
The progesterone receptor was detected  not only in well-characterized  target tissues, i.e., 
in  glands and  luminal  epithelium,  but also in  stromal cells (some displayed  the  strongest 
reaction), in mesothelium,  and in fibers of smooth muscles. Only in cell nuclei, whether or 
not the animals received an injection of progesterone was an antigen revealed corresponding 
to the B subunit (and/or to the A subunit, because there is immunoreactivity  of IgG-RB with 
both hormone-binding  subunits A and B). The 90,000-mol-wt  protein  was revealed in both 
cytoplasm  and  nuclei.  These immunohistological  data suggest that  the concept  of steroid 
action that necessarily involves the original formation of the hormone-receptor complexes in 
the cytoplasm before translocation to the nucleus, may have to be revised. 
In biochemical and histological studies, steroid hormone re- 
ceptors have usually been studied using radioactive hormonal 
ligand binding. Only recently, antibodies to steroid receptors 
have become available (see the review in reference 1), allowing 
the detection of the receptor molecules themselves, independ- 
ently of hormone binding. Therefore it becomes possible  to 
reveal histologically both steroid-free and -occupied receptors 
under several physiological, pathological; and pharmacologi- 
cal conditions, and  in  particular,  to compare the  receptor 
state in untreated and steroid hormone-treated animals. 
In spite of the increasing availability of antibodies to recep- 
tors, there are only a  few published immunohistochemical 
studies.  The glucocorticosteroid receptor has been demon- 
strated in  cultured cells,  using immunofluorescence (2,  3). 
The  estrogen  receptor has  been  observed in  rat  pituitary 
gonadotropic, lactotropic, and somatotropic cells at the elec- 
tron microscopic level (4), and in tumoral mammary cells at 
the light microscope level (5). The difficulties encountered in 
this  new  way  of studying steroid hormone receptors may 
come from the lack of monospecificity of polyclonal antibod- 
ies raised against highly, but not completely, purified receptor. 
With monoclonal antibodies, a recent report reveals the estro- 
gen receptor in a number of estrogen target cells of mammal- 
ian reproductive tissues (6). In any case, the fixation condi- 
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ment of the  receptor within  the cell  or alter the antigenic 
determinants. 
The chick oviduct is a  system of choice for the study of 
steroid  hormone  action.  In  particular,  progesterone  is  in- 
volved in differentiation and protein synthesis of  oviduct cells 
in the glands and the luminal epithelium (7,  8). The proges- 
terone receptor (PR)' is increased after estradiol treatment of 
the chicken (9). We have obtained polyclonal antibodies IgG- 
G3 (10), raised against the nontransformed "8S" form of PR 
(8S-PR). The 8S-PR preparations contain the A and B pro- 
gesterone-binding subunits  (Mr  =  79,000  and  110,000,  re- 
spectively; see reference  11) and a  nonprogesterone-binding 
protein (Mr = 90,000: see references 12 and 13); the tentative 
stoichiometry is one molecule of A or B for two molecules of 
90,000  Mr per one 8S-PR oligomere (14).  IgG-G3 interact 
with  both the progesterone-binding subunits  B and A  and 
with  the  nonprogesterone-binding  component  (90,000-Mr 
protein) (12).  We also raised polyclonal antibodies IgG-RB 
(15) against the purified B subunit (16), which react with both 
B and A  but not with the 90,000-Mr protein. Furthermore, 
we  have  described  a  monoclonal  antibody  BF4  (17)  that 
recognizes the 90,000 Mr protein but not A and B. The present 
report gives a full account of the observations made with the 
three antibodies and that use improved conditions of fixation. 
Progress towards understanding of the structure of the chick 
oviduct PR (12-14) helps to interpret the immunohistochem- 
ical observations. Preliminary publications have reported a 
few data obtained with IgG-G3 and BF4 (18), and with IgG- 
RB (19). 
MATERIALS  AND  METHODS 
Antibodies:  Antibiodies have been recently described in references 10, 
15, and 17. The specificity  studies included density-geadlent experiments and 
Western immunoblolting analysis on crude and purified receptor components. 
IgG-G3 (10) is an immunoglobin fraction of an antiserum raised in a goat 
against the noutransformed, molybdate-stab'dized 8S-PR (20). It recognized the 
nontransformed 8S-PR, as well as its constituents released after transformation 
of the receptor, the subunits A and B and the 90,000-M, component (12). IgG- 
RB (15)  is the immunogiobulin fraction of an antiserum raised in a  rabbit 
against the purified B subunit of  PR (16). IgG-RB reacted with B and A subunlts 
(15).  BF4 (17)  is a  rat monoclonal antibody obtained against the nontrans- 
formed 8S-PR, and interacting selectively with an immunogenic determinant 
of the 90,000-Mr  component (13).  This 90,000-Mr  protein was shown to be 
present also in  the untransformed, molybdate-stab~  8S-forms of other 
steroid hormone receptors,  for androgens, estrogens, and glucocorticosteroids 
(13), and it is present in other chick cells in equal or even higher amount than 
in the oviduct cell, (Catelli,  M. G., N. Binart, B. Moncharmont, and J.-M. 
Gasc; unpublished observations). 
The polyclonal antibodies were routinely used after presaturation with, either 
for IgG-G3, ovalbumin, conalbumin (50 #g/ml), and normal chicken serum 
(1:100), or, for IgG-RB, normal chicken serum alone (1:100). 
Preparation  of Animals  and  Tissues:  Chickens of the Warren 
strain were used. 1  -wk-old female chickens  received, by intramuscular  injection, 
1 nag of estradiol benzoate in sesame oil for 10 d. After an interruption of 1 
wk, they again were injected with five daily identical injections. At the end of 
the second stimulatory treatment, the oviduct weighed -1.8 g and cells con- 
mined a mean of ~40,000 [~Hlprogesterone  binding sites per cell (21). In some 
experiments, oviducts were  used before any hormonal treatment of chicken 
1Abbreviations used in  this paper: BF-4,  rat  monoclonal  antibody 
obtained against the nontransformed 8S progesterone receptor; IgG- 
G3, immunoglobulin fraction of antiserum raised in a  goat against 
the nontransformed 8S progesterone receptor; IgG-RB, immunoglob- 
ulin fraction of an antiserum raised in a goat against the B subunit of 
progesterone receptor; PR; progesterone receptor;  8S-PR, nontrans- 
formed 8S progesterone receptor. 
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(immature animals), or al~er only five estradiol injections (primostimuLation), 
or after a withdrawal of 4 wk following  the last injection of the  10M initial 
estradiol treatment. After decapitation the oviduct was immediately removed. 
A slice was taken in the middle part of the magnum, washed in cold PBS, cut 
into two to four pieces,  and fixed in appropriate fixative fluids. The longest 
side of each piece was not >5 mm. 
Several fixatives  were used and compared. Fixation, washes, and dehydration 
processes  were carried out in an ice hath. The best detection of  PR was obtained 
with the four following fixatives: (a) Bonin's fluid for 60-80 rain, followed by 
several washes in 70% ethanol; (b) Carnoy's fluid for 60-80 rain, followed by 
several washes  in absolute ethanol; (c) glutamldehyde  (0.5%) in 0.1 M Soerensen 
buffer, pH 7.4,  for 90 rain, followed  by several washes in either Soerensen 
buffer or PBS; (d) absolute ethanol +  1% acetic acid for 60-80 min, followed 
by several washes in absolute ethanol. 
Dehydration was made in graded ethanol when needed, and terminated in 
l-butanol before embedding in paraffin. The whole process from fixation to 
embedding was carried out within 7 h. 
Immunohistochemical Procedure:  Paraffin sections (thickness 7 
~m) were deparaffinized, rehydrated, and rinsed in PBS. The immunoperoxi- 
dase technique included the use of a  biotinylated secondary antibody and 
avidin-biotin-peroxidase complex to label the secondary antibody (Vectastain 
reagents, Vector Laboratories, Burlingame, CA). Sections were first incubated 
in  3%  nonimmune serum of the animal species in which the biotinylated 
secondary antibody was raised. This and all subsequent steps were carried out 
at  room temperature.  The excess of serum was removed and the primary 
antibody was placed on the sections (90-120  rain).  After washing in PBS, 
sections received the secondary biotinylated antibody (dilution 1:400; 30 rain). 
The secondary antibody was washed in PBS and replaced by the avidin-biotin- 
peroxidase complex (30  min).  After washing, the  peroxidase activity was 
revealed by 3-3'-diaminobenzidin tetrahydrochloride (0.5 mg/ml) in presence 
of 0.01%  H202, in Tris buffer, pH 7.6. Sections were then rinsed, dehydrated, 
and mounted. 
The total protein concentrations of  the three antibody preparations and their 
usual dilutions were 40 mg/ml and 1:1,000 to 1:4,000 for IgG-GS,  13 mg/ml 
and 1:250 to 1:500 for IgG-RB, and 2 mg/ml and l:l,000 to 1:4,000 for BF4. 
Controls were run on adjacent sections placed on the same histological slide. 
They included immunnglobnlin fractions from nonlmmune or preimmune 
sera, dilution of specific antibodies up to extinction of staining, and presatura- 
tion with heterolngous antigens (ovalbumin, conalbumin, calmodulin, avidin) 
and with different preparations of PR. The 8S-PR used for presaturation was 
obtained after affinity chromatography and ion-exchange (DEAE-Sephacel, 
Pharmaeia, Uppsala, Sweden)  chromatography in presence of Na2MoO4; this 
purified 8S-PR preparation was used after concentration on DEAE-Sephacel 
in absence of molybdate, a maneuver yielding activated receptor preparation 
containing A, B, and 90,000-Mr protein (12). The B subunit was prepared as 
described (16). The 90,000-Mr protein was prepared by immunoaffinity chro- 
matography on Sepharose-BF4 (Catelli,  M. G., and B. Moncharmont, unpub- 
lished method). For presaturation, antibody (see dilutions above) and antigen 
(2-10 #g/ml of PR components and >10 ug/ml for other antigens) were mixed 
at the desired dilution and incubated overnight at 4°C. Mixtures were then used 
on sections instead of antibodies alone. For BF4, the nonimmune control was 
obtained with culture medium of an IgG-nonsecreting myeloma line added to 
nonimmune rat IgGs at the same concentration as in BF4 preparations. 
All controls not including an anti-PR antibody were negative, except for the 
endogenous peroxidase activity of red blood cells. However, a slight positivity 
of goat nonimmune  IgGs was observed in some cells of the luminal epithelium 
after glutaraldehyde fixation. 
RESULTS 
For each of the three antibodies, we describe the most repre- 
sentative  data  obtained  in  the  oviduct  of chicken  having 
received the second estrogen stimulation, using the four fixa- 
tion procedures. Thereafter we report on animals under other 
hormonal treatments. 
Immunohistochemical Studies with IgG-G3 
When treated with IgG-O3, sections of oviduct from estra- 
dioMnjected chickens showed specific staining in cytoplasm 
and nuclei of cells of the luminal epithelium, glands, stroma, 
and mesothelium. The nuclei of smooth muscle fibers were 
also positive. The most complete staining was observed after 
glutaraldehyde (Fig.  I a) and acidified-ethanol fixations. The 
histological quality however was often poor, and staining in FIGURE  1  immunoperoxidase  staining with  IgG-G3  of  estradiol-treated  chick  oviduct sections,  in absence  of  progesterone 
treatment. A strong reaction is observed in cytoplasm and nuclei of the luminal epithelium and in nuclei of glands and stroma (a). 
The cytoplasm of glandular and stromal  cells is only weakly stained.  When  IgG-G3 was  pres~,turated by purified 90,000 M,- 
protein (b), the cytoplasmic staining in all cell types was  reduced  up to  near  extinction, whereas the nuclear staining is only 
weakly reduced. When IgG-G3 was presaturated  simultaneously by the purified 90,000-M, protein and B subunit (c) all staining, 
cytoplasmic and  nuclear, was  abolished.  Preimmune  immunoglobulins (d)  produce  in the  luminal epithelium the weak,  but 
constant, staining that appears to be similar in intensity to the weak staining observed after presaturation by 90,000-Mr protein 
(b) or 90,000-Mr protein and B subunit (c). Glutaraldehyde fixation; no counterstaining. Bar, 20 v.m. x  650. 
the  cytoplasm of the  luminal  epithelium and  glands  were 
weak. After Carnoy's fixation there was no nuclear staining, 
and after Bouin's fixation the glands were only weakly and 
occasionally stained. 
After presaturation of IgG-G3 with 8S-PR preparation, all 
staining was abolished in all cell types of the oviduct, both in 
cytoplasm and nuclei (not shown). Presaturation of IgG-G3 
with the 90,000-Mr protein abolished the cytoplasmic staining 
(incompletely,  however,  after  glutaraldehyde  fixation), 
whereas  the  nuclear  reaction  was  apparently  not,  or  only 
slightly modified (Fig.  1  b). The remaining weak but constant 
cytoplasmic staining  observed with  glutaraldehyde fixation 
did  not  disappear  even  after a  large  excess of 90,000-Mr 
protein; it should be noted that similar weak reaction was 
always obtained in the cytoplasm of epithelial cells  treated 
with nonimmune goat serum and fixed with glutaraldehyde 
(Fig.  1  d). Presaturation of IgG-G3 simultaneously with the 
90,000-Mr protein and B subunit suppressed the cytoplasmic 
and nuclear staining (Fig.  1  c), except for a weak cytoplasmic 
staining in the luminal epithelium, similar to that reaction 
observed with preimmune IgGs (Fig.  1  d). 
Immunohistochemical Studies with IgG-RB 
With IgG-RB, a nuclear staining was observed in the cells 
of the luminal  epithelium, glands,  stroma (Fig.  2a),  meso- 
thelium (Fig. 2c), and smooth muscular cells (Fig. 2d), after 
all fixation procedures but the Carnoy's. This negative result 
confirmed that the Carnoy's fixative is unable to preserve, on 
sections from the same oviduct, the nuclear antigens revealed 
with the three other fixations. No cytoplasmic staining com- 
petitive  by  any  PR  preparation  was  observed  in  luminal 
epithelial and glandular cells. 
Presaturation of IgG-RB with 8S-PR (not shown) as well as 
with the B subunit (Fig. 2 b) abolished all nuclear staining in 
all cell types. Conversely presaturation with a purified 90,000- 
Mr protein did not modify the nuclear staining in any type of 
cells (not shown). 
Immunohistochemical Studies with BF4 
With  all  fixatives,  an  intense  staining  was  observed  in 
cytoplasm of epithelial  cells  after treatment  with  the  BF4 
monoclonal antibody and  a  positive reaction also was  ob- 
served in nuclei, although less strongly (Fig. 3 a). Nuclei were 
also well stained in glandular cells (Fig.  3 a), stroma, meso- 
thelium (Fig. 3 e), and muscular cells. However, only acidified 
alcohol fixation yielded a strong and constant reaction in the 
cytoplasm of glandular cells (Fig. 3 b) and of other cell types. 
Presaturation by the 8S-PR (not shown) or the 90,000-Mr 
purified protein (Fig.  3 c) resulted in complete extinction of 
all reactions in nuclei and cytoplasm. Presaturation with the 
B subunit did not reduce the staining in nuclei and cytoplasm 
(Fig. 3d). 
As with the two other antibodies, the most complete distri- 
bution of staining was observed after acidified ethanol and 
glutaraldehyde fixations, which, however, frequently gave a 
poor histological picture (Fig. 3 a). 
In Fig. 3 e, we show immunostaining of mesothelium cells 
with BF4: both cytoplasm and nuclei are positive, in contrast 
to the only nuclear localization of antigen revealed by IgG- 
RB (Fig. 2 c). 
Animals under Different Hormonal Conditions 
Chickens during primostimulation by estrogen showed the 
G^sc ET At.  Chick  Oviduct Progesterone  Receptor  1195 FIGURE 2  Immunoperoxidase staining  with  IgG-RB of estradiol-treated  chick  oviduct  sections,  in  absence  of  progesterone 
treatment. Cell nuclei in the luminal epithelium, the glands, and the stroma are positive when the antibody is applied alone (a), 
whereas no nuclear staining remains when the antibody was presaturated  by a purified preparation of the B subunit of PR (b). 
Some stromal  cells (long arrows  in a) are very strongly  stained,  and others  (short arrows  in a) are not stained.  In the luminal 
epithelium two groups of nuclei differ by the intensity of the reaction: those located at the basis of the epithelium are as strongly 
stained as glandular cell nuclei, whereas those at the apex of the epithelium are weakly or not stained. (c) The estradiol treatment 
induces on the outer surface of the oviduct, between the smooth muscle fibers and the mesothelium, the formation of vesicles 
full of fluid and loose stromal tissue; such a vesicle is shown here bordered by mesothelial cells whose nuclei are strongly stained 
by the reaction with the anti-B subunit antibody. (cO In smooth muscle fibers, a reaction with the anti-PR antibody is observed in 
the nuclei.  The weak cytoplasmic reaction is due to a contaminant as indicated by the lack of saturability of this reaction by a 
purified B subunit preparation which completely abolishes the nuclear staining (not shown). The presence of nuclear PR revealed 
by IgG-RB is remarkable  because no progesterone  was administered to the animal. (a, b, and CO Glutaraldehyde fixation. (c) 
Bouin's fixative; no counterstaining.  Bar, 20 #m. x  650. 
same distribution of positive cells with the three antibodies as 
at the end of the secondary stimulation. 
In animals withdrawn from estrogen treatment for 4  wk, 
the staining with IgG-G3 was weak and mostly nuclear (not 
shown). With lgG-RB, it was only nuclear (Fig. 4 a). BF4 only 
reacted in the cytoplasm of luminal epithelium and glandular 
cells  (Fig.  4b).  The  BF4  staining  in  the  cytoplasm  of the 
glands was more easily revealed in withdrawn animals than 
in fully stimulated chickens, possibly because the absence of 
secretory granules allowed a  better reaction  of the  receptor 
1196  THE JOURNAL OF  CELL BIOLOGY - VOLUM[  99, 1984 FIGURE 3  Immunoperoxidase staining  with  BF4  of estradiol-stimulated  chick  oviduct  sections,  in  absence  of  progesterone 
treatment. After glutaraldehyde fixation (a), BF4 reveals the antigenic determinant of the 90,000-Mr  protein in cytoplasm  and 
nuclei of the luminal epithelium, and in nuclei of glands and  stroma.  In cytoplasm  of glands the reaction is weak. The poor 
histological  quality of the section  is the consequence of an insufficient fixation in glutaraldehyde necessary for the preservation 
of the antigenic determinant in nuclei.  After acidified-alcohol fixation (b), BF4 reacts in cytoplasm and nuclei of the glands with 
equal intensity.  All staining is abolished (c) when BF4 was preincubated with purified 90,000-Mr protein, whereas the staining is 
unchanged  (d) after preincubation with the B subunit.  In mesothelial cells (e) BF4 stains cytoplasm  and  nuclei,  unlike IgG-RB 
which in the same cells reveals the B subunit only in the nuclei (Fig. 2c). (a) Glutaraldehyde fixation; (b, c, d, and e) Acidified 
alcohol fixation; no counterstaining.  Bar, 20 #m. x  650. 
with the antibody. Glutaraldehyde,  which best permitted the 
detection  of the  90,000-Mr  protein  in  estrogen-stimulated 
animals, was not used with oviduct of withdrawn chickens. 
For that reason we cannot rule out the presence of 90,000-M~ 
protein in nuclei of oviducts of the withdrawn chickens. 
Immature chickens that never received any estradiol  injec- 
GAsc ET ^L.  Chick  Oviduct Progesterone  Receptor  1197 FIGURE 4  Immunoperoxidase  staining of PR of chick oviduct sections, in absence of estradiol  and progesterone  treatment. (a) 
Immunoperoxidase  staining with IgG-RB of a chick oviduct section, after 4 wk of hormonal withdrawal. The B subunit is revealed 
in nuclei of glands and luminal epithelium. The presence of a weak cytoplasmic reaction in the epithelium cannot be excluded. 
However, the nuclear staining appears much stronger although this animal never received progesterone, and had not received 
estradiol for 4 wk. (b) In the same animal as in a, the immunoperoxidase  staining with BF4 is still strong in the cytoplasm of the 
luminal epithelium and weak in nuclei. In the glands, almost devoid of secretion granules, the 90,O00-M, protein is more easily 
revealed than in estradiol-stimulated oviduct (see Fig. 3a). (c) Immunoperoxidase  staining with IgG-RB of an oviduct section from 
immature, untreated chicken.  As in withdrawn animals (a) the cytoplasm  may also be weakly stained. The size and density of the 
nuclei in the epithelium leaves little space to observe clearly the cytoplasm and no definitive conclusion can be drawn as to the 
presence of small amounts of cytoplasmic B subunit. (a and c) Bouin's fixative; (b) Camoy's fixative; no counterstaining.  Bar, 20 
~m. x  650. 
tion  had  no glands.  The  oviduct  was only composed of a 
stroma lined inwards with the luminal epithelium and out- 
wards with some muscle fibers and a fiat epithelium (meso- 
thelium). Cells of the luminal epithelium were stained with 
IgG-G3 in the cytoplasm and nuclei, with IgG-RB in nuclei 
only (Fig. 4 c), and with BF4 in the cytoplasm and also weakly 
in  the  nuclei.  Cells  of the  mesothelium  were  occasionally 
stained in nuclei with IgG-RB. The stromal cells showed a 
weak and diffuse reaction with BF4 that could not be distin- 
guished with certainty from a background staining. 
In all  these different hormonal  conditions,  presaturation 
experiments always gave identical results to those obtained at 
the end of the secondary estrogen stimulation. 
In addition,  studies were also conducted in progesterone- 
or dexamethasone-treated chickens, either fully stimulated by 
the second estrogenic stimulation, after the primary stimula- 
tion,  or in  the  withdrawn  state;  they were killed  1 h  after 
hormone injection.  The same distribution  of positive cells 
was observed as in Fig.  1-4 for animals not receiving these 
two hormones. In particular, the distribution of positive cells, 
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and the relative intensity of staining in the cytoplasm and the 
nuclei were the same. 
Semiquantitative estimations were carried out with IgG-G3 
and IgG-RB. The intensity of the nuclear staining was related 
to the extent of estradiol stimulation: it was greatest after the 
secondary estrogen stimulation, followed by the primary stim- 
ulation, then the withdrawn state, and finally the nonstimu- 
lated animals. 
DISCUSSION 
PR Subunits Are Revealed in Target Cells with 
Specific Antibodies and Suitable 
Fixation Conditions 
The  immunohistochemical data  reported here should  be 
interpreted  in  the  light  of the  properties of the  antibodies 
used. IgG-G3 recognizes the intact nontransformed 8S-PR, as 
welt as its progesterone-binding components A  and  B, and 
nonprogesterone-binding  90,000-Mr  protein  (12),  although 
the definitive stoichiometry in the 8S-PR preparation is not known  (14).  One  should  take  also  into  account  that  the 
nontransformed "8S" forms of other steroid hormone recep- 
tors also contain the 90,000-Mr protein antigen (13). IgG-RB 
(15) does not detect the 90,000-M~  protein, but reacts with 
both B and A subunits of the progesterone receptor. Finally, 
only BF4 reveals the 90,000-Mr protein; we have already seen 
that this is a component of all tested 8S-steroid receptors and 
that there is an excess of 90,00-Mr protein over the amount 
necessary to account for these receptors; the reason for this is 
unknown. 
The techniques presented here have been worked out after 
many different trials to optimize the fixation conditions and 
to best preserve the antigenic determinants. A suitable fixation 
of glands is difficult mostly because of the large abundance of 
secretory granules,  which  is an  obstacle to the  reaction  of 
other antigens with their antibodies (for an example, compare 
Figs.  3 a  and 4 b). Antigenic preservation is satisfactory only 
when  the  tissues  are  left  in  the  fixatives  for  60-90  min. 
Previously we had used 5-6-h fixation times, but it appeared 
that  small  pieces  of tissue  were  usually  overfixed in  such 
conditions. Glutaraldehyde had been used at  1%, instead of 
0.5%  now. These modifications account for the differences 
between our present and preliminary observations (18). Com- 
parative studies with  frozen cryostat sections are currently 
underway;  our first results (19)  are in  full agreement with 
those obtained here with paraffin sections. 
This work reveals, besides the expected PR-containing tar- 
get cells in glands and the luminal epithelium, other target 
cells in stroma, smooth muscles, and mesothelium. The rather 
strong reaction recorded in some stromal cells (Fig. 2 a) should 
lead to more research to discover the effects of progesterone 
in these cells. 
PR Subunits Are All Revealed by Specific 
Antibodies in Target Cell Nuclei 
The use of the three antibodies, and the availability of three 
related antigens in purified forms that were used in presatu- 
ration experiments, allowed precise examination of the sub- 
cellular distribution of the PR components. In the cytoplasm, 
there is no immunoreaction with IgG-RB, whereas the im- 
munoreaction observed with IgG-G3 and BF4 is completely 
abolished by presaturation with 90,000-Mr protein (and nat- 
urally also 8S-PR). We conclude that the 90,000-Mr protein 
is present in the cytoplasm, and that no antigen corresponding 
to the  B  or A  subunit  is detectable under  our conditions, 
whatever the hormonal condition is. In the nuclei, the three 
antibodies  give an  immunoreaction,  but the  results of the 
presaturation experiments differ according to the case:  IgG- 
RB staining is completely extinguished by purified B and by 
8S-PR, but not by 90,000-Mr protein; the staining by BF4 is 
abolished by the 90,000-Mr protein and 8S-PR, but not by 
the purified B; the reaction observed with IgG-G3 is abolished 
by 8S-PR or by the simultaneous addition of B and 90,000- 
Mr protein; however, extinction is only partial after presatu- 
ration with only the B subunit, the remaining staining being 
attributable to either some 90,000-M, protein or to residual 
staining  of the  cytoplasm surrounding  and  underlying  the 
nucleus. The decrease of IgG-G3 nuclear staining by presat- 
uration of the 90,000-Mr protein alone is difficult to assess, 
and weak in any case. We conclude from these data that there 
exist in nuclei both progesterone-binding subunits A and/or 
B and 90,000-Mr protein. 
Histochemical Nuclear Receptor vs. Biochemical 
Cytosol Receptor 
In terms of receptor subcellular distribution, there is much 
contradiction  between the  immunohistochemical data  and 
the biochemical results published  so far.  Measurements of 
specific  progesterone-binding  macromolecules in  estrogen- 
stimulated animals, in absence of progesterone, indicate that 
they are mostly, if not totally,  found in the cytosol (high- 
speed  supernatant)  fraction  of the  homogenate,  and  con- 
versely absent in the nuclear fraction (21). This seems in strict 
opposition to what  is observed by immunohistochemistry, 
which only demonstrates the presence in nuclei of the proges- 
terone-binding receptor units A and B. It is very unlikely that 
the immunohistochemical observations are due to artifactual 
translocation of PR from cytoplasm to nucleus during fixa- 
tion. Recently, the nuclear localization of PR was confirmed 
on  frozen sections (19),  i.e.,  is under conditions excluding 
almost certainly such an artifact. Cryostat sections were ob- 
tained from chick oviduct explants and incubated in vitro in 
presence of the  radioactive  progestin  [3H]Org  2058.  They 
were  processed  for  autoradiography  and/or  immunohisto- 
chemistry with IgG-RB. At the periphery of the explants, cell 
nuclei were revealed by both techniques,  indicating the nu- 
clear localization of hormone-PR complexes. In cells in the 
central part of the  explants,  no radioactive ligand  was de- 
tected, indicating that the hormone had not reached the inner 
cells, whereas PR was still detected immunochemically in the 
nuclei. No cytoplasmic receptor was observed. Therefore, one 
now should  envisage that the biochemical results obtained 
after homogenization may be due to the artificial relocation 
of  PR in the cytosol fraction of the homogenate. Uncontrolled 
extraction from the nucleus during the homogenization proc- 
ess  would  be  due  to  the  low  affinity  of PR  for  nuclear 
constituents,  since it is nontransformed in  absence of hor- 
mone (review in reference 22). However, this hypothesis has 
yet to be directly substantiated. The absence ofimmunostain- 
ing with IgG-RB in the cytoplasm may be even a false negative 
result,  the  corresponding  antigen  being  altered  during  the 
procedure and/or present in too low levels to be detected. It 
is also possible that low levels of endogenous progesterone in 
immature chickens are sufficient to promote the location of 
the receptor in the nucleus, but not the hormonal response 
which  would  require  higher  levels of progesterone. In any 
case, immunohistological evidence has been presented for the 
presence of steroid receptor in the cytoplasm of several target 
cells (2-5). 
Nuclear "Inactive"  Receptor and Hormone 
Action 
Measuring the receptor in the nuclear fraction of oviduct 
homogenate after hormonal exposure has been interpreted in 
terms of "translocation" into the nucleus, based on its pres- 
ence in the cytosol in absence of hormone. The immunohis- 
tological observation of the nuclear location of PR, whether 
or not progesterone has been administered, argues against the 
concept that the initial formation and location of hormone- 
receptor complexes in the cytoplasm is mandatory to trigger 
steroid hormone action in the target cells. Therefore the results 
reported in this paper challenge the dogma designating the 
transfer  to  the  nucleus  as  a  limiting  step  in  the  cellular 
response. If all or some of the receptor is already situated in 
the nucleus in absence of hormone, then the hormone may 
reach it directly there, and eventually provokes its "transfor- 
G^sc  ET  At.  Chick Oviduct Progesterone Receptor  ] 199 mation" or "activation" in situ, this last step being possibly 
decisive in the response to hormone. Transformation or ac- 
tivation  is  poorly understood:  it  is  usually  defined by the 
increase of affinity for a nuclear structure called "acceptor" 
on the basis of binding to nuclei, and this fits well with the 
recovery of hormone-receptor complexes in the nuclear frac- 
tion of homogenates. The recovery in the nuclear fraction of 
all hormone-binding components of the receptor, but not of 
nontransformed 8S-receptor, would then result from the in- 
creased  affinity  of the  hormone-receptor complexes  after 
dissociation of the oligomere, releasing the 90,000-Mr protein 
from hormone-binding units,  which probably would be ac- 
companied by changes of conformation of these  subunits. 
That the presence of receptor in the nuclear fraction is not 
necessarily  linked  to  agonist  hormonal  activity,  has  been 
already suggested when  it was observed that  such  antihor- 
mones as  antiestrogen  (23)  or antiglucocorticosteroid (24), 
even though displaying no agonistic hormonal activity, also 
increase the binding of the receptor for the nuclear fraction. 
It has already been shown that the estradiol receptor devoid 
of hormone is almost all  nuclear in the  liver of immature 
female and male chickens (25).  Moreover, when the present 
work was complete and the manuscript ready to be sent out, 
two interesting communications, dealing with the mammal- 
ian estrogen receptors, confirmed ourirecent (l 9) and present 
findings with the chick PR:  both the  results obtained with 
monoclonal antibodies to estrogen receptor (6) and the data 
observed after separation of nuclei by cytochalasin B (26) also 
indicated the nuclear localization of  the cytosol (nonoccupied) 
and nuclear forms of the receptors. 
We then have to admit that the presence of the receptor in 
the nucleus, whether unfilled by hormone or complexed to 
antihormone, does not lead per se to hormone action. There- 
fore, one should distinguish "really active" hormone-receptor 
complexes, which naturally must be nuclear in order to pro- 
mote hormone action, from nonactive receptor (free or bind- 
ing antihormone), which may also be situated in the nucleus. 
It is therefore not "translocation" from cytoplasm to nucleus 
that then definitively differentiates receptors engaged in hor- 
mone action from receptors not engaged in hormone action. 
What is important is the nature of interaction(s) of the active 
form of the receptor with the chromatin machinery. Recent 
biochemical studies have indicated  the selective binding in 
chromatin of (active) hormone-receptor complexes, but not 
of antihormone-receptor complexes (27).  The initial (in ab- 
sence of hormone) distribution  of the receptor between the 
nucleus and the extra nuclear compartment of the cell  may 
vary according to species,  organs, and hormones, and not be 
crucial for determining the hormone response. 
In summary, this report on immunocytochemical localiza- 
tion of PR in the chicken oviduct indicates, owing to the use 
of different fixation procedures and to availability of several 
antibodies and preparations of PR components (a) that PR is 
present  in  most cell  types of the  differentiated  oviduct  of 
estrogen-treated chickens, but only in the epithelial cells  of 
the immature, non-estrogen-treated chicken oviduct; (b) that 
the PR is present in the cell nuclei of immature chickens, and 
that  progesterone  administration  does  not  modify  signifi- 
cantly  the  picture;  (c)  that  there  is  no  direct  or  indirect 
evidence for the presence of the progesterone-binding B and/ 
or A subunits of PR in the cytoplasm of estrogen-stimulated 
chicken oviduct; (d) that the 90,000 non-progesterone-bind- 
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ing protein component of nontransformed 8S-PR is present 
in the cytoplasm and the nuclei of the same cells containing 
the B and/or A subunits in their nuclei; (e) that the concept 
of steroid action  involving necessarily the formation in the 
cytoplasm  of hormone  (antihormone)-receptor  complexes 
may have to be revised. In fact, with respect to this last point, 
we suggest that the necessary and sufficient active hormone- 
receptor complexes may be formed in the nucleus in which 
the unoccupied receptor is originally present and where the 
gene response will take place. 
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